DaBomb Protein Biotech Corp. (TPEX:6578)
15.75
+0.05 (0.32%)
Apr 29, 2026, 1:30 PM CST
DaBomb Protein Biotech Revenue
In the year 2025, DaBomb Protein Biotech had annual revenue of 309.34M TWD, down -8.43%. DaBomb Protein Biotech had revenue of 80.90M in the quarter ending December 31, 2025, a decrease of -0.95%.
Revenue
309.34M
Revenue Growth
-8.43%
P/S Ratio
3.65
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 309.34M | -28.49M | -8.43% |
| Dec 31, 2024 | 337.82M | -46.59M | -12.12% |
| Dec 31, 2023 | 384.41M | -49.22M | -11.35% |
| Dec 31, 2022 | 433.63M | -37.00M | -7.86% |
| Dec 31, 2021 | 470.63M | -134.59M | -22.24% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| We Can Medicines | 3.22B |
| Jia Jie Biomedical | 485.40M |
| Lian Fa International Dining Business | 1.17B |
| Wonder Pets Enterprises | 3.21B |
| Tai Roun Products | 3.33B |
| Hantech Bio-Technology | 778.54M |
| Ten Ren Tea | 2.16B |
| SunWay Biotech Co., LTD. | 951.52M |